IBSA USA
Will Bellucci is an experienced sales representative with a diverse background in specialty pharmaceuticals, advertising, and account management. Currently serving as a Specialty Sales Representative at IBSA USA since March 2022, Bellucci focuses on endocrinology and pain management products, working alongside healthcare professionals. Prior to this role, Bellucci was a Senior Sales Executive at Wire & Cable Specialties, Inc., where business relationships were built in various industries including outdoor sporting goods and medical devices. Additional experience includes advertising account management at Goddard Systems, affiliate sales and marketing at Starz, and sales management training at Enterprise Rent-A-Car. Bellucci holds a B.S. in Marketing from West Chester University of Pennsylvania.
This person is not in any teams
IBSA USA
IBSA USA is the subsidiary of IBSA Group, the largest privately owned pharmaceutical company in Switzerland. IBSA is committed to improving patient quality of life through research, innovation, and the development of effective drugs and cutting-edge technologies. IBSA USA markets two unique levothyroxine formulations in the U.S. for the treatment of hypothyroidism: Tirosint® (levothyroxine sodium) capsules and Tirosint®-SOL (levothyroxine sodium) oral solution. IBSA also markets Licart™ (diclofenac epolamine) topical system 1.3%, the only once-a-day topical nonsteroidal anti-inflammatory (NSAID) available in the U.S. to treat acute pain due to minor strains, sprains, and contusions. IBSA is focused on the health and well-being of patients and driven by the desire to bring therapeutic alternatives to as many people as possible. IBSA Group bases its philosophy on four sustainable pillars: Person, Innovation, Quality, and Responsibility. For more information about Tirosint, Tirosint-SOL, or Licart, including Full Prescribing Information, go to each brand’s respective website.